Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Hepatocellular Carcinoma Treatment and Prognosis, and Diet, Metabolism, and Disease.
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysis
<scp>MetALD</scp>: New Perspectives on an Old Overlooked Disease
Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States
TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial
Call to action—Pediatric MASLD requires immediate attention to curb health crisis
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis
Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019
Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly
Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019
Global epidemiology of alcohol‐associated liver disease in adolescents and young adults
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 Analysis
Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers
The burden of alcohol and substance use disorders in adolescents and young adults
Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women
Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting
Relationship of non-invasive measures with histological response in patients with nonalcoholic steatohepatitis and fibrosis: 52-week data from the Phase 3 MAESTRO-NASH trial
The global burden of metabolic disease: Data from 2000 to 2019
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective